Find uplifting stories about heroes, innovations, and solutions
71 results for "macular degeneration"
A wireless eye implant that restored central vision to people with late-stage macular degeneration just secured $230 million to bring the technology to Americans. The device pairs high-tech glasses with a retinal implant to help people see again after 12 months of use.
Scientists in Finland developed a gentle heat treatment that activates the eye's natural repair systems before dry macular degeneration causes vision loss. Human trials start this spring for a condition affecting 20 million Americans over 40.
A retinal implant that restores vision for people with macular degeneration just got approved in Europe, letting patients read books and road signs again. Americans could access the life-changing device by 2027.
Millions face vision loss from age-related macular degeneration, but simple lifestyle changes can help delay or prevent the condition. An NYU ophthalmologist shares science-backed steps anyone can take today.
Researchers discovered molecules that protect the eye cells responsible for reading, recognizing faces, and seeing color. The breakthrough could lead to the first treatments for age-related macular degeneration, a leading cause of blindness.
A common diabetes medication may protect aging eyes from one of the leading causes of blindness. People over 55 taking metformin were significantly less likely to develop macular degeneration over five years.
Researchers discovered a simple fatty acid injection that restores vision in older mice by targeting an aging gene. The breakthrough could help millions facing age-related vision loss and macular degeneration.
Researchers at UC Irvine have restored failing vision in older mice using a targeted fatty acid therapy, offering new hope for treating age-related blindness. The breakthrough could one day help millions of older adults regain sight lost to macular degeneration.
A wireless retinal implant smaller than a grain of rice is restoring vision to people blinded by macular degeneration, with over 80% of trial participants now able to read letters and words after years in darkness. The breakthrough offers hope to 5 million people worldwide living with advanced AMD.
Researchers at University of Rochester Medicine received NIH funding to develop a breakthrough treatment that could stop macular degeneration before it steals vision from millions of older adults. The new therapy targets a protein that drives the disease at its earliest stages.
Scientists in Finland developed a gentle heat treatment that helps aging eyes repair themselves before dry macular degeneration causes vision loss. Human trials begin this spring for a condition affecting 20 million Americans.
Johns Hopkins researchers discovered how vitamin A and thyroid hormones help babies develop sharp central vision before birth, overturning a 30-year-old theory. The breakthrough could lead to new treatments for macular degeneration and other blinding diseases.
Scientists discovered that erucamide, a naturally occurring molecule in the eye, helps coordinate the retina's defense against damage and could slow degenerative eye diseases affecting millions. The breakthrough offers hope for a new approach to treating conditions like macular degeneration and diabetic retinopathy.
Millions of older adults with wet macular degeneration could soon trade monthly eye injections for a tiny implant that only needs refilling every six months. European regulators just approved Susvimo, the first treatment of its kind that delivers medicine continuously inside the eye.
A cheap, widely available diabetes medication could save millions from the most common cause of blindness in older adults. Researchers found metformin reduces age-related macular degeneration progression by more than a third.
Scientists developed a gene therapy that could reduce painful monthly eye injections for macular degeneration patients down to just once or twice a year. The breakthrough offers hope to nearly 20 million Americans battling the leading cause of vision loss in older adults.
A tiny chip implanted in the eye is giving blind people their sight back, allowing them to read novels, draw pictures, and solve puzzles again. Europe just approved the device for sale, with U.S. approval potentially coming soon.
A rice-sized implant with living cells is now FDA-approved to slow vision loss in MacTel patients, offering hope to thousands losing their sight. For the first time, people with this rare retinal disease have a real chance to preserve their independence.
Scientists discovered that when you picture something in your mind's eye, your brain activates the exact same neurons used for actually seeing it. This breakthrough could help researchers restore sight to people with vision loss.
A single injection of experimental drug Axpaxli kept vision stable for up to a year in patients with age-related blindness, potentially reducing treatment burden. The Phase 3 trial showed significantly better durability than the current standard treatment.
Showing 20 of 71